Raffles Medical Group (RFMD SP, BSL.SI) is a healthcare company listed on the Singapore Exchange (SGX). The company provides a range of healthcare services, including primary care, specialist medical services, and hospital services. In this article, we will focus on Raffles Medical Share Price and provide an overview of the company’s financial performance, factors that affect its share price, its ownership structure, and its investment prospects. We will also highlight the independent research available on Smartkarma, a leading investment research platform where top independent analysts publish their research on companies such as Raffles Medical.
Raffles Medical Group’s Financial Performance
Raffles Medical Group’s financial performance has been relatively stable in recent years. In 2021, the company reported a revenue of SGD 546.9 million, up 1.2% from the previous year. However, the company’s net profit after tax decreased by 35.4% to SGD 41.9 million due to the impact of the COVID-19 pandemic. Raffles Medical’s earnings per share also decreased by 37.4% from SGD 4.02 in 2020 to SGD 2.52 in 2021.
Despite the challenging environment, Raffles Medical has continued to expand its services and facilities. The company opened a new medical centre in Raffles Place, Singapore, in 2021, which provides specialist medical services, general practice, and diagnostic imaging services. Raffles Medical has also announced plans to build a new hospital in Shanghai, China, which is expected to open in 2025.
Factors Affecting Raffles Medical Share Price
Raffles Medical’s share price is influenced by various factors, including the company’s financial performance, industry developments, and market trends. For example, Raffles Medical’s share price may increase if the company reports better-than-expected financial results or if there is positive news in the healthcare industry. Conversely, the company’s share price may decrease if it reports weak financial results or if there is negative news in the healthcare industry.
Over the past five years, Raffles Medical’s share price has fluctuated between SGD 0.92 and SGD 1.62. The share price has been relatively stable in recent months, with the stock trading at around SGD 1.00 to SGD 1.10.
Is Raffles Medical a Good Stock?
Raffles Medical has been a consistent performer in the healthcare industry in Singapore. The company’s strong brand recognition, diversified business lines, and strategic expansion plans are some of its strengths. However, Raffles Medical also faces competition from other healthcare companies, as well as regulatory risks and operational challenges.
Investors interested in Raffles Medical can benefit from the independent research available on Smartkarma. Top independent analysts, such as Geoff Howie, Jason Yap, CFA, Kemp Dolliver, CFA, Maybank Research, Shifara Samsudeen, ACMA, CGMA, Tina Banerjee, and Xinyao (Criss) Wang, have written great research on Raffles Medical on Smartkarma, providing valuable insights into the company’s financial performance, competitive landscape, and investment prospects.
Ownership of Raffles Medical Group
Raffles Medical is a private healthcare company, with no government ownership. The company’s major shareholders are the founders of Raffles Medical, Dr. Loo Choon Yong and Dr. Alfred Loh. As of 31 December 2021, Dr. Loo and Dr. Loh owned 29.82% and 29.49% of Raffles Medical’s shares, respectively.
Healthcare Stocks to Buy in Singapore
Raffles Medical is one of the top healthcare stocks to consider investing in, along with other prominent healthcare companies such as Singapore Medical Group, IHH Healthcare, and Q&M Dental Group. These companies operate in different segments of the healthcare industry, providing a range of services to customers in Singapore and other parts of the world. Investors interested in the healthcare sector can benefit from the growth potential of these companies, as demand for healthcare services is expected to continue to rise in Singapore and other countries.
Conclusion
Raffles Medical Group is a leading healthcare company in Singapore, providing a range of services to customers across the country. The company’s financial performance has been relatively stable, despite the challenges posed by the COVID-19 pandemic. Raffles Medical’s share price is influenced by various factors, including the company’s financial performance, industry developments, and market trends.
Investors interested in Raffles Medical can benefit from the independent research available on Smartkarma, where top independent analysts provide valuable insights into the company’s financial performance, competitive landscape, and investment prospects. Raffles Medical is one of the top healthcare stocks to consider investing in, along with other prominent healthcare companies such as Singapore Medical Group, IHH Healthcare, and Q&M Dental Group.
Overall, Raffles Medical Group’s strong brand recognition, diversified business lines, and strategic expansion plans make it a good stock to consider investing in for investors looking to gain exposure to the healthcare sector in Singapore.
